Phosphoprotein network analysis of white adipose tissues unveils deregulated pathways in response to high-fat diet

Asfa Alli Shaik1, Beiying Qiu1, Sheena Wee1

  • 1Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, 61 Biopolis Drive, Singapore 138673, Singapore.

Scientific Reports
|May 17, 2016
PubMed

Insights

Obesity disrupts cell signaling. This study maps protein phosphorylation changes in mouse fat tissue, revealing new targets like ACSS2 that impact lipid metabolism and insulin response.

Area of Science:

  • Molecular Biology
  • Metabolic Disorders
  • Proteomics

Background:

  • Signaling pathway dysregulation in obesity is not fully understood.
  • White adipose tissue (WAT) plays a critical role in metabolic homeostasis.
  • Phosphoproteomics offers a way to study dynamic signaling events.

Purpose of the Study:

  • To comprehensively map the phosphoproteome of WAT in diet-induced obesity.
  • To identify novel signaling pathways and protein phosphorylation sites involved in obesity.
  • To investigate the functional role of specific altered phosphosites in metabolic regulation.

Main Methods:

  • Global phosphoproteomic analysis of WAT from mice on low-fat diet (LFD) and high-fat diet (HFD).
  • Quantification of phosphorylation levels on thousands of peptides.
  • Bioinformatic analysis including kinase-substrate prediction and network analysis.
  • Functional validation using site-directed mutagenesis of a key phosphosite on ACSS2.

Main Results:

  • Identified significant differential phosphorylation at 282 phosphosites across 191 proteins in response to HFD.
  • Revealed alterations in insulin-responsive proteins and enzymes critical for lipid homeostasis.
  • Discovered a novel HFD-regulated phosphosite (S263) on ACSS2; mutation led to hypertriglyceridemia and impaired AKT phosphorylation.
  • Network analysis suggested deregulation of lipogenic and lipolytic pathways.

Conclusions:

  • Provides a detailed phosphoproteomic map of adipose tissue in obesity.
  • Identifies ACSS2 phosphorylation as a key regulator in diet-induced obesity.
  • Highlights numerous novel candidate phosphorylation sites for future functional studies in metabolic disease.